Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-10-08

Clinical Trial Update: Subarachnoid Hemorrhage Recovery And Galantamine [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on recovery after subarachnoid hemorrhage evaluating galantamine in Phase 1/Phase 2, with completed status and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Galantamine (galantamine)

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Subarachnoid Hemorrhage | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-10-08